Coming off a $44.5 million series A financing in late 2016, TCR2 Therapeutics Inc. snagged another $125 million in an oversubscribed series B financing to advance programs using its T-Cell Receptor Fusion Construct (TRuC) platform. (See BioWorld Today, Dec. 9, 2016.) Read More
Sun Pharmaceutical Industries Ltd., the Mumbai, India-based pharma giant known more for its footprint in generics than in novel drug development, gained FDA approval of Ilumya (tildrakizumab-asmn) to treat adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Read More
In an effort to advance regulatory science and bring the clinical trial process into the 21st century, the FDA is looking at a trade-off with sponsors – more engagement with agency staff on complex innovative trial designs in exchange for more public disclosure about what goes into those designs and how they work. Read More
HONG KONG – South Korea is looking to artificial intelligence (AI) to spearhead drug development in hopes of catching up with its Western peers and securing a stronger foothold in the global market. Read More
HONG KONG – Travecta Therapeutics Pte Ltd. is the latest startup to join Singapore's biotech block. The newly formed drug discovery company is based on intellectual property derived from discoveries made at Duke-NUS Medical School (Duke-NUS). Read More
Eleven Biotherapeutics Inc., of Cambridge, Mass., said institutional and accredited investors participated in the registered direct offering and purchased 7.96 million shares at $1.13 each, for gross proceeds of approximately $9 million. Read More
Genentech, of South San Francisco, a member of the Roche Group, said the FDA approved Lucentis (ranibizumab) 0.3 mg prefilled syringe as a new method of administering treatment for all forms of diabetic retinopathy. Read More
Eiger Biopharmaceuticals Inc., of Palo Alto, Calif., disclosed FDA guidance on its hepatitis D virus (HDV) program, including agreement that a single, registration trial can support an NDA filing. Read More
